Lonza | LONN - Gross Profit On Sales

Stock Price
536.20
Daily Change
4.20 0.79%
Monthly
-1.94%
Yearly
-5.70%
Q1 Forecast
523.37

Lonza reported CHF1.29B in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.46B 70M Sep/2025
AstraZeneca USD 12.39B 5M Dec/2025
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 488M 64M Sep/2025
Demant DKK 8.82B 277M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.39B 147M Dec/2025
Geberit CHF 649.4M 189.8M Mar/2025
Genmab DKK 868M 195M Jun/2025
Givaudan CHF 823M 575M Jun/2024
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GN Store Nord DKK 2.5B 344M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Johnson Matthey GBP 480M 33M Jun/2024
Merck EUR 3.21B 186M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Philips EUR 2.29B 377M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Sika AG CHF 3.13B 69.3M Jun/2025
Smith & Nephew USD 2.09B 117M Dec/2025
Solvay EUR 265M 13M Sep/2025
UCB EUR 2.46B 520M Dec/2024